N C Karyotakis - Concepedia

Concepedia

Author

N C Karyotakis

The University of Texas MD Anderson Cancer Center

Also Known As

N C Karyotakis, N. C. Karyotakis, N.C. Karyotakis, Nicholas C. Karyotakis, Nicholas Karyotakis

13

Publications

1.6K

Citations

10

H-Index

23

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center University of California San Diego The University of Texas at Austin Assistance Publique – Hôpitaux de Paris University Hospital of Bern

NC

About

N C Karyotakis is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	1.4K
2	Immunology	4	4	189
3	Gastroenterology	2	2	99
4	Health Sciences	1	1	26
5	Hepatology	1	1	1.2K

N C Karyotakis

×

10

Publications

1.6K

Citations

10

H-Index

	Year	Citations
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
Correlation between In Vitro and In Vivo Activity of Antifungal Agents against Candida Species E. Anaissie, N C Karyotakis, R. Hachem, The Journal of Infectious Diseases	1994	116
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt, The Lancet. Gastroenterology & hepatology InflammationAnti-inflammatoryImmunologyGastroenterologyMaintenance Therapy	2021	89
Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis E. Anaissie, Ray Hachem, N C Karyotakis, Antimicrobial Agents and Chemotherapy Murine TrichosporonosisMedicinal ChemistryAntifungal AgentExperimental TherapyAmphotericin B Deoxycholate	1994	64
Comparison of the Efficacy of Polyenes and Triazoles against Hematogenous Candida krusei Infection in Neutropenic Mice N C Karyotakis, E. Anaissie, Ray Hachem, The Journal of Infectious Diseases	1993	41
The new antifungal azoles: fluconazole and itraconazole N C Karyotakis, Elias Anaissie Current Opinion in Infectious Diseases New TriazolesAntifungal AgentFungal VirusAntifungal AgentsMedicine	1994	36
Efficacy of escalating doses of liposomal amphotericin B (AmBisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice N C Karyotakis, E. Anaissie Antimicrobial Agents and Chemotherapy Antifungal AgentAmphotericin B DesoxycholateHealth SciencesAntiparasitic AgentAntifungal Agents	1994	26
Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections N C Karyotakis, María Cecilia Dignani, Ray Hachem, Antimicrobial Agents and Chemotherapy	1995	17
Efficacy of continuous flucytosine infusion against Candida lusitaniae in experimental hematogenous murine candidiasis N C Karyotakis, E. Anaissie Antimicrobial Agents and Chemotherapy	1996	11
Effects of cyclophosphamide and ceftriaxone on gastrointestinal colonization of mice by Candida albicans George Samonis, N C Karyotakis, E. Anaissie, Antimicrobial Agents and Chemotherapy Antifungal AgentDysbiosisCandida DisseminationCandida AlbicansMedicine	1996	10

Page 1